Primary tabs

miRNAs as Evaluation Biomarker of Tuberculosis Treatment Response

Asif Mohammed from the International Centre for Genetic Engineering and Biotechnology in India will identify miRNA patterns as potential biomarkers as per Receiver Operating Characteristics, to identify quantitative patterns of circulating human miRNAs which can be used as early biomarkers to predict outcome of the anti-TB drug therapy. They will follow-up patients during their course of treatment with first line anti-TB drugs, and will isolate, sequence, identify and quantitate circulating miRNAs in sputum and plasma of these individuals at one month, two month and 6/9 months of treatment.

Grant ID
GCE-India/R1/2017/001
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
5000000.00
Funding Currency
INR
Exchange Rate (at time of payment)
0.0153800000
Funding Amount (in USD)
76900.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
Funding Total (In US dollars)
76900.00
Co-Funded
False